BCIQ Profiles

Company Profile ReportTarget Profile Report
DIST_0802_s43018-021-00237-1

ESK981 identified as PIKFYVE inhibitor and prostate cancer candidate

Aug 27, 2021 | 9:16 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Prostate cancer

A University of Michigan-led team showed that ESK981, a multi-tyrosine kinase inhibitor that

Read the full 312 word article

How to gain access

Continue reading with a
two-week free trial.